HKG:6955 Revenue

In the year 2025, Shandong Boan Biotechnology had annual revenue of 784.82M CNY with 8.06% growth. Shandong Boan Biotechnology had revenue of 391.41M in the half year ending December 31, 2025, with 9.67% growth.

Revenue

784.82M CNY

Revenue Growth

+8.06%

P/S Ratio

4.85

Revenue / Employee

1.10M CNY

Employees

714

Market Cap

4.24B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	784.82M	58.51M	8.06%
Dec 31, 2024	726.32M	108.19M	17.50%
Dec 31, 2023	618.13M	102.17M	19.80%
Dec 31, 2022	515.96M	357.26M	225.11%
Dec 31, 2021	158.70M	-	-
Dec 31, 2020	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Qyuns Therapeutics	897.99M
TYK Medicines	117.25K
BioDlink International Company	831.99M
Clover Biopharmaceuticals	3.90M
Mirxes Holding Company	166.32M
Viva Biotech Holdings	1.92B
Antengene Corporation	117.22M
Jacobio Pharmaceuticals Group	59.56M

Revenue Rankings